nach oben

AIDS and Behavior

Erschienen in:

01.03.2016 | Original Paper

Factors Associated with Prescription of Opioids and Co-prescription of Sedating Medications in Individuals with HIV

verfasst von: Jessica S. Merlin, Ashutosh Tamhane, Joanna L. Starrels, Stefan Kertesz, Michael Saag, Karen Cropsey

Erschienen in: AIDS and Behavior | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Opioids are often prescribed for chronic pain, and opioid risks such as overdose and death are heightened when opioids are co-prescribed with other sedating medications. We investigated factors associated with chronic opioid prescription, alone and in combination with benzodiazepines and muscle relaxants, in a clinical cohort of individuals with HIV. We used multivariable logistic regression models to determine participant clinical and demographic characteristics that are associated with chronic prescription of opioids or chronic co-prescription of opioids with sedating medications. Among 1474 participants, chronic prescription of opioids occurred in 253 individuals (17.2 %), and chronic co-prescription occurred in 90 individuals (6.1 %). Age >50, public insurance as compared to private insurance, and symptoms of depression and anxiety were significantly associated with chronic opioid prescription and chronic co-prescription. Our findings raise concern that opioid prescription and co-prescription of sedating medications occurs disproportionately in patients for whom use is riskier.

Nur mit Berechtigung zugänglich

Collaboration ATC. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293–9.CrossRef

Balderson BH, Grothaus L, Harrison RG, McCoy K, Mahoney C, Catz S. Chronic illness burden and quality of life in an aging HIV population. AIDS Care. 2013;25(4):451–8.CrossRefPubMedPubMedCentral

Edelman EJ, Gordon KS, Glover J, McNicholl IR, Fiellin DA, Justice AC. The next therapeutic challenge in HIV: polypharmacy. Drugs Aging. 2013;30(8):613–28.CrossRefPubMedPubMedCentral

Daubresse M, Chang HY, Yu Y, Viswanathan S, Shah ND, Stafford RS, et al. Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000–2010. Med Care. 2013;51(10):870–8.CrossRefPubMed

Miaskowski C, Penko JM, Guzman D, Mattson JE, Bangsberg DR, Kushel MB. Occurrence and characteristics of chronic pain in a community-based cohort of indigent adults living with HIV infection. J Pain. 2011;12(9):1004–16.CrossRefPubMedPubMedCentral

Merlin JS, Cen L, Praestgaard A, Turner M, Obando A, Alpert C, et al. Pain and physical and psychological symptoms in ambulatory HIV patients in the current treatment era. J Pain Symptom Manage. 2012;43(3):638–45.CrossRefPubMedPubMedCentral

Merlin JS, Westfall AO, Raper JL, Zinski A, Norton WE, Willig JH, et al. Pain, Mood, and Substance Abuse in HIV: Implications for Clinic Visit Utilization, ART Adherence, and Virologic Failure. J Acquir Immune Defic Syndr. 2012;61(2):164–70.CrossRefPubMedPubMedCentral

Newshan G, Bennett J, Holman S. Pain and other symptoms in ambulatory HIV patients in the age of highly active antiretroviral therapy. J Assoc Nurses AIDS Care. 2002;13(4):78–83.CrossRefPubMed

Aouizerat BE, Miaskowski CA, Gay C, Portillo CJ, Coggins T, Davis H, et al. Risk factors and symptoms associated with pain in HIV-infected adults. J Assoc Nurses AIDS Care. 2010;21(2):125–33.CrossRefPubMedPubMedCentral

10.

Cervia LD, McGowan JP, Weseley AJ. Clinical and demographic variables related to pain in HIV-infected individuals treated with effective, combination antiretroviral therapy (cART). Pain Med. 2010;11(4):498–503.CrossRefPubMed

11.

Edelman EJ, Gordon K, Becker WC, Goulet JL, Skanderson M, Gaither JR, et al. Receipt of Opioid Analgesics by HIV-Infected and Uninfected Patients. J Gen Intern Med. 2012;28(1):82–90.CrossRefPubMedPubMedCentral

12.

Silverberg MJ, Ray GT, Saunders K, Rutter CM, Campbell CI, Merrill JO, et al. Prescription long-term opioid use in HIV-infected patients. Clin J Pain. 2012;28(1):39–46.CrossRefPubMedPubMedCentral

13.

Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;1:CD006605.PubMed

14.

Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305(13):1315–21.CrossRefPubMed

15.

Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152(2):85–92.CrossRefPubMedPubMedCentral

16.

Johnson EM, Lanier WA, Merrill RM, Crook J, Porucznik CA, Rolfs RT, et al. Unintentional prescription opioid-related overdose deaths: description of decedents by next of kin or best contact, Utah, 2008–2009. J Gen Intern Med. 2012;. doi:10.1007/s11606-012-2225-z.

17.

Kuehn BM. Methadone overdose deaths rise with increased prescribing for pain. JAMA. 2012;308(8):749–50.CrossRefPubMed

18.

Webster LR, Cochella S, Dasgupta N, Fakata KL, Fine PG, Fishman SM, et al. An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med. 2011;12(Suppl 2):S26–35.CrossRefPubMed

19.

Webster LR. Considering the risks of benzodiazepines and opioids together. Pain Med. 2010;11(6):801–2.CrossRefPubMed

20.

Skurtveit S, Furu K, Bramness J, Selmer R, Tverdal A. Benzodiazepines predict use of opioids–a follow-up study of 17,074 men and women. Pain Med. 2010;11(6):805–14.CrossRefPubMed

21.

Paulozzi LJ, Kilbourne EM, Shah NG, Nolte KB, Desai HA, Landen MG, et al. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med. 2012;13(1):87–95.CrossRefPubMed

22.

Oliver P, Keen J. Concomitant drugs of misuse and drug using behaviours associated with fatal opiate-related poisonings in Sheffield, UK, 1997–2000. Addiction. 2003;98(2):191–7.CrossRefPubMed

23.

Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012;125(1–2):8–18.CrossRefPubMedPubMedCentral

24.

Gudin JA, Mogali S, Jones JD, Comer SD. Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use. Postgrad Med. 2013;125(4):115–30.CrossRefPubMedPubMedCentral

25.

Merlins JS, Tucker RO, Saag MS, Selwyn PA. The role of palliative care in the current HIV treatment era in developed countries. Top Antivir Med. 2013;21(1):20–6.PubMed

26.

Starrels JL PD, Fox AD, Merlin J, Arnsten JH, Cunningham CO. HIV Treatment providers’ perspectives on opioid prescribing for chronic pain: the overriding concern to retain patients in care [oral abstract presentation]. Paper presented at: Association of Medical Education and Research in Substance Abuse, November 8, 2013, Bethesda.

27.

Burkholder GA, Tamhane AR, Appell LE, Willig JH, Saag MS, Raper JL, et al. Short Communication: Viral Suppression Is Associated with Increased Likelihood of Colorectal Cancer Screening Among Persons Living with HIV/AIDS. AIDS Res Hum Retroviruses. 2015;31(5):519–24.CrossRefPubMed

28.

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.CrossRefPubMedPubMedCentral

29.

Mathews WC, May S. EuroQol (EQ-5D) measure of quality of life predicts mortality, emergency department utilization, and hospital discharge rates in HIV-infected adults under care. Health Qual Life Outcomes. 2007;5:5.CrossRefPubMedPubMedCentral

30.

Newcombe DA, Humeniuk RE, Ali R. Validation of the world health organization alcohol, smoking and substance involvement screening test (ASSIST): report of results from the Australian site. Drug Alcohol Rev. 2005;24(3):217–26.CrossRefPubMed

31.

Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158(16):1789–95.CrossRefPubMed

32.

P. A. Logistic regression using the SAS system. Publisher: SAS Institute Inc. Edition: August 2003.

33.

Weisberg DF, Gordon KS, Barry DT, Becker WC, Crystal S, Edelman EJ, et al. Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected Patients. J Acquir Immune Defic Syndr. 2015;69(2):223–33.CrossRefPubMed

34.

Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;171(7):686–91.CrossRefPubMed

35.

Paulozzi LJ, Mack KA, Hockenberry JM. Division of Unintentional Injury Prevention NtCfIPaC, C. D. C. Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines—United States, 2012. MMWR Morb Mortal Wkly Rep. 2014;63(26):563–8.PubMed

36.

Gaither JR, Goulet JL, Becker WC, Crystal S, Edelman EJ, Gordon K, et al. Guideline-concordant management of opioid therapy among human immunodeficiency virus (HIV)-infected and uninfected veterans. J Pain. 2014;. doi:10.1016/j.jpain.2014.08.004.PubMedPubMedCentral

37.

Dobscha SK, Morasco BJ, Duckart JP, Macey T, Deyo RA. Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain. Clin J Pain. 2013;29(2):102–8.CrossRefPubMedPubMedCentral

38.

Dobscha SK. Prescription opioids and benzodiazepines: moving beyond “just say no”. Pain Med. 2013;14(10):1447–9.CrossRefPubMed

39.

Cropsey KL, Stevens EN, Valera P, Brendan Clark C, Bulls HW, Nair P, et al. Risk factors for concurrent use of benzodiazepines and opioids among individuals under community corrections supervision. Drug Alcohol Depend. 2015;. doi:10.1016/j.drugalcdep.2015.06.038.PubMed

40.

Richards BL, Whittle SL, van der Heijde DM, Buchbinder R. The efficacy and safety of muscle relaxants in inflammatory arthritis: a cochrane systematic review. J Rheumatol Suppl. 2012;90:34–9.CrossRefPubMed

41.

Sullivan MD, Howe CQ. Opioid therapy for chronic pain in the United States: promises and perils. Pain. 2013;154(Suppl 1):S94–100.CrossRefPubMedPubMedCentral

42.

Rogers KD, Kemp A, McLachlan AJ, Blyth F. Adverse selection? A multi-dimensional profile of people dispensed opioid analgesics for persistent non-cancer pain. PLoS One. 2013;8(12):e80095.CrossRefPubMedPubMedCentral

43.

Sullivan MD, Edlund MJ, Zhang L, Unützer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 2006;166(19):2087–93.CrossRefPubMed

44.

Sullivan MD, Edlund MJ, Steffick D, Unützer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain. 2005;119(1–3):95–103.CrossRefPubMed

45.

Edlund MJ, Martin BC, Devries A, Fan MY, Braden JB, Sullivan MD. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain. 2010;26(1):1–8.CrossRefPubMedPubMedCentral

46.

Parsells Kelly J, Cook SF, Kaufman DW, Anderson T, Rosenberg L, Mitchell AA. Prevalence and characteristics of opioid use in the US adult population. Pain. 2008;138(3):507–13.CrossRefPubMed

47.

Simoni-Wastila L, Ritter G, Strickler G. Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst Use Misuse. 2004;39(1):1–23.CrossRefPubMed

48.

Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend. 2013;131(3):263–70.CrossRefPubMedPubMedCentral

49.

Lum PJ, Little S, Botsko M, Hersh D, Thawley RE, Egan JE, et al. Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S91–7.CrossRefPubMed

50.

Perry BA, Westfall AO, Molony E, Tucker R, Ritchie C, Saag MS, et al. Characteristics of an ambulatory palliative care clinic for HIV-infected patients. J Palliat Med. 2013;. doi:10.1089/jpm.2012.0451.PubMedPubMedCentral

51.

Önen NF, Barrette EP, Shacham E, Taniguchi T, Donovan M, Overton ET. A review of opioid prescribing practices and associations with repeat opioid prescriptions in a contemporary outpatient HIV clinic. Pain Pract. 2012;12(6):440–8.CrossRefPubMedPubMedCentral

52.

Johnson A, Condon KD, Mapas-Dimaya AC, Schrager J, Grossberg R, Gonzalez R, et al. Report of an HIV clinic-based pain management program and utilization of health status and health service by HIV patients. J Opioid Manag. 2012;8(1):17–27.CrossRefPubMed

Titel: Factors Associated with Prescription of Opioids and Co-prescription of Sedating Medications in Individuals with HIV
verfasst von: Jessica S. Merlin
Ashutosh Tamhane
Joanna L. Starrels
Stefan Kertesz
Michael Saag
Karen Cropsey
Publikationsdatum: 01.03.2016
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 3/2016
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-015-1178-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Factors Associated with Prescription of Opioids and Co-prescription of Sedating Medications in Individuals with HIV

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2016

Dual Epidemics of Drug Use and Syphilis Among Chinese Female Sex Workers: Results of Eight Consecutive Cross-Sectional Surveys from 2006 to 2013 in Qingdao, China

Differences in Relationship Characteristics Between HIV-Negative Male Couples Who Used and Did Not Use Substances with Sex

Correlates of Alcohol Use Among Patrons of Alcohol Consumption Venues in Botswana

Adherence to Tobacco Dependence Treatment Among HIV-Infected Smokers

Marijuana Use as a Sex-Drug is Associated with HIV Risk Among Black MSM and Their Network

“Such Behaviors Are Not in My Home Village, I Got Them Here”: A Qualitative Study of the Influence of Contextual Factors on Alcohol and HIV Risk Behaviors in a Fishing Community on Lake Victoria, Uganda

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin